Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cemtrex (CETX) Research & Development (2017 - 2025)

Cemtrex (CETX) has disclosed Research & Development for 9 consecutive years, with $501435.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 43.66% year-over-year to $501435.0, compared with a TTM value of $2.0 million through Dec 2025, down 42.2%, and an annual FY2025 reading of $2.4 million, down 29.91% over the prior year.
  • Research & Development was $501435.0 for Q4 2025 at Cemtrex, up from $298603.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.9 million in Q1 2023 and bottomed at -$627723.0 in Q3 2023.
  • Average Research & Development over 5 years is $838890.7, with a median of $856644.0 recorded in 2023.
  • The sharpest move saw Research & Development tumbled 180.11% in 2023, then surged 210.36% in 2024.
  • Year by year, Research & Development stood at $1.1 million in 2021, then soared by 43.37% to $1.5 million in 2022, then plummeted by 44.82% to $848805.0 in 2023, then grew by 4.86% to $890083.0 in 2024, then plummeted by 43.66% to $501435.0 in 2025.
  • Business Quant data shows Research & Development for CETX at $501435.0 in Q4 2025, $298603.0 in Q3 2025, and $386565.0 in Q2 2025.